These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
842 related articles for article (PubMed ID: 17270543)
21. Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population. Alvandi E; Akrami SM; Chiani M; Hedayati M; Nayer BN; Tehrani MR; Nakhjavani M; Pedram M Thyroid; 2011 Apr; 21(4):373-82. PubMed ID: 21309721 [TBL] [Abstract][Full Text] [Related]
22. RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience. Abdelhakim A; Barlier A; Kebbou M; Benabdeljalil N; Timinouni M; Taoufiq F; Roche C; El Antri S J Cancer Res Ther; 2009; 5(3):198-202. PubMed ID: 19841562 [TBL] [Abstract][Full Text] [Related]
23. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. Marsh DJ; Robinson BG; Andrew S; Richardson AL; Pojer R; Schnitzler M; Mulligan LM; Hyland VJ Genomics; 1994 Sep; 23(2):477-9. PubMed ID: 7835899 [TBL] [Abstract][Full Text] [Related]
25. [Hereditary thyroid cancer can be cured by prophylactic surgery]. Wallin G; Bondesson AG; Farnebo LO; Hallengren B; Hamberger B; Jansson S; Nilsson O; Nordenskjöld M; Smeds S; Svensson KA; Wihlborg O; Zedenius J Lakartidningen; 2001 Jun; 98(25):3024-8. PubMed ID: 11462876 [TBL] [Abstract][Full Text] [Related]
26. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC. Chiefari E; Chiarella R; Crocetti U; Tardio B; Arturi F; Russo D; Trischitta V; Filetti S; Zingrillo M Horm Metab Res; 2001 Jan; 33(1):52-6. PubMed ID: 11280716 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients. Fernández RM; Navarro E; Antiñolo G; Ruiz-Ferrer M; Borrego S Int J Mol Med; 2006 Apr; 17(4):575-81. PubMed ID: 16525712 [TBL] [Abstract][Full Text] [Related]
28. Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic. Jindrichová S; Vcelák J; Vlcek P; Neradilová M; Nemec J; Bendlová B J Endocrinol; 2004 Nov; 183(2):257-65. PubMed ID: 15531714 [TBL] [Abstract][Full Text] [Related]
29. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature]. de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023 [TBL] [Abstract][Full Text] [Related]
30. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011 [TBL] [Abstract][Full Text] [Related]
32. A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease. Dvoráková S; Dvoráková K; Malíková M; Skába R; Vlcek P; Bendlová B J Pediatr Surg; 2005 Jun; 40(6):e1-6. PubMed ID: 15991157 [TBL] [Abstract][Full Text] [Related]
33. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family]. Benazzouz B; Hafidi A; Benkhira S; Chraibi A; Kadiri A; Hilal L Bull Cancer; 2008 Apr; 95(4):457-63. PubMed ID: 18495576 [TBL] [Abstract][Full Text] [Related]
34. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor]. Amosenko FA; Brzhezovskiĭ VZh; Liubchenko LN; Shabanov MA; Kozlova VM; Vanushko VE; Kazubskaia TP; Gar'kavtseva RF; Kalinin VN Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527 [TBL] [Abstract][Full Text] [Related]
35. [Prophylactic thyroidectomy in carriers of RET oncogene mutation carriers]. Høie J; Heimdal K; Nesland JM; Børmer O Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3249-52. PubMed ID: 11187163 [TBL] [Abstract][Full Text] [Related]
36. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes. Skinner MA; Wells SA Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335 [TBL] [Abstract][Full Text] [Related]
37. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease. Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566 [TBL] [Abstract][Full Text] [Related]
38. [Prophylactic thyroidectomy in children at risk for medullary thyroid carcinoma]. Torres de Aguirre A; Martínez Carol A; Cabello Laureano R; García Valles C; Gómez Gila A; del Valle Núñez J Cir Pediatr; 2005 Jul; 18(3):106-8. PubMed ID: 16209369 [TBL] [Abstract][Full Text] [Related]
39. Management of medullary thyroid carcinoma. Jiménez C; Hu MI; Gagel RF Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338 [TBL] [Abstract][Full Text] [Related]
40. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation. Frank-Raue K; Raue F Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]